Article

P03-02. SCID-hu mice generate HIV specific human immune responses after gp96 vaccination

2009-01-01

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 52fe7847-9d8c-5204-ad09-70d2fd774dd7
DOI: 10.1186/1742-4690-6-s3-p19
PMCID: PMC2767681

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

P03-02. SCID-hu mice generate HIV specific human immune responses after gp96 vaccinationDOI 10.1186/1742-4690-6-s3-p19Read

Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteersSemantic proximity Read

Innate-like memory T cells rapidly emerge in humans after gene therapy for SCID-X1Semantic proximity Read

[Advances in AIDS vaccines].Semantic proximity Read

Generation of Functional Human T Cell Development in NOD/SCID/IL2rγ <sup>null</sup> Humanized Mice Without Using Fetal Tissue: Application as a Model of HIV Infection and PersistenceSemantic proximity Read

Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunitySemantic proximity Read

HIV immune evasin Nef enhances allogeneic CAR T cell potencySemantic proximity Read

The human immune system in hu-PBL-SCID miceSemantic proximity Read

Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR649–684, a mucosal subunit HIV/AIDS vaccine candidateSemantic proximity Read

A novel humanized mouse model to study the function of human cutaneous memory T cells <i>in vivo</i> in human skinSemantic proximity Read

Inhibition of caspase pathways limits CD4+ T cell loss and restores host anti-retroviral function in HIV-1 infected humanized mice with augmented lymphoid tissueSemantic proximity Read

EV01: A phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc ConsortiumSemantic proximity Read

The anti-caspase 1 inhibitor VX-765 reduces immune activation, CD4 <sup>+</sup> T cell depletion, viral load and total HIV-1 DNA in HIV-1 infected humanized miceSemantic proximity Read